Alzheimer’s Association Calls on CMS to Reverse Its Decision to Severely Limit Access to FDA-Approved Alzheimer’s Disease Treatments

Alzheimer’s Association Hosts Inaugural State Dementia Services Coordinator Summit

Alzheimer’s Association Statement On Gantenerumab Phase 3 Topline Data Release